BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8522492)

  • 1. The immunopathogenesis of cutaneous T-cell lymphoma.
    Rook AH; Heald P
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):997-1010. PubMed ID: 8522492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
    J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells.
    Rook AH; Vowels BR; Jaworsky C; Singh A; Lessin SR
    Arch Dermatol; 1993 Apr; 129(4):486-9. PubMed ID: 8466223
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse large cell non-Hodgkin's lymphoma, CD30+, T-cell phenotype.
    Gruson LM; Latkowski JA
    Dermatol Online J; 2005 Dec; 11(4):17. PubMed ID: 16403389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-lymphoma effect.
    Richard C; Bermúdez A; Izu R
    Br J Haematol; 2010 Apr; 149(2):166. PubMed ID: 20015300
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell technology in the diagnosis & management of cutaneous T-cell lymphoma.
    Duncan KO; Heald PW
    Compr Ther; 1998 Mar; 24(3):117-22. PubMed ID: 9559245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of cutaneous lymphoma ].
    Beylot-Barry M; Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
    Belousova IE; Kazakov DV; Krivolapov IuA
    Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T-cell lymphoma: a model for selective immunotherapy.
    Edelson RL
    Cancer J Sci Am; 1998; 4(2):62-71. PubMed ID: 9532405
    [No Abstract]   [Full Text] [Related]  

  • 12. [CD56-positive 'natural killer'/T-cell lymphoma].
    Bekkenk MW; Willemze R
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1524-5. PubMed ID: 11569462
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft-versus-T-cell non-Hodgkin's lymphoma effect.
    Hsiao LT; Chiou TJ; Wang WS; Chen PM
    Int J Hematol; 2006 Apr; 83(3):193. PubMed ID: 16720545
    [No Abstract]   [Full Text] [Related]  

  • 14. Photoinactivated lymphocyte therapy of cutaneous T-cell lymphoma.
    Heald P; Knobler R; LaRoche L
    Dermatol Clin; 1994 Apr; 12(2):443-9. PubMed ID: 8045055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamic interplay of malignant and benign T cells in cutaneous T-cell lymphoma.
    Herrick C; Heald P
    Dermatol Clin; 1997 Jan; 15(1):149-57. PubMed ID: 9001868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis and therapy of cutaneous T cell lymphoma.
    Kim EJ; Hess S; Richardson SK; Newton S; Showe LC; Benoit BM; Ubriani R; Vittorio CC; Junkins-Hopkins JM; Wysocka M; Rook AH
    J Clin Invest; 2005 Apr; 115(4):798-812. PubMed ID: 15841167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier.
    Ohmatsu H; Sugaya M; Fujita H; Miyagaki T; Kadono T; Maeda D; Takazawa Y; Fukayama M; Tamaki K; Sato S
    Acta Derm Venereol; 2010 May; 90(3):324-5. PubMed ID: 20526566
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma, ear-type: a unique cutaneous T-cell lymphoma with a favourable prognosis.
    Géraud C; Goerdt S; Klemke CD
    Br J Dermatol; 2011 Feb; 164(2):456-8. PubMed ID: 20969565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.